Zydus Lifesciences reported a 14% YoY net profit rise to Rs 911 crore for Q2FY25, driven by strong sales in India and the US. Revenue grew 20% YoY to Rs 5,237 crore. However, QoQ profit and revenue declined. EBITDA rose 27.5% YoY.
| Subscribe To Our Free Newsletter |
